
Torrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 13, 2021, titled "Torrent Pharma Enters Into Voluntary Licensing Agreement with Lilly for Baricitinib for Covid-19 in India".
Filed with NSE ·

Torrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 13, 2021, titled "Torrent Pharma Enters Into Voluntary Licensing Agreement with Lilly for Baricitinib for Covid-19 in India".
6ix hasn’t read this filing yet.
Torrent Pharmaceuticals Ltd on 6ix
Follow Torrent Pharmaceuticals into a list and get an email when it puts out news.
Follow Torrent Pharmaceuticals